Global transdermal drug delivery system market is expected to grow with a CAGR of 4.3% over the forecast period from 2019-2025

NEW YORK, Jan. 16, 2020 /PRNewswire/ — The report on the global transdermal drug delivery system market provides qualitative and quantitative analysis for the period from 2017 to 2025....

NEW YORK, Jan. 16, 2020 /PRNewswire/ —

The report on the global transdermal drug delivery system market provides qualitative and quantitative analysis for the period from 2017 to 2025.

Read the full report: https://www.reportlinker.com/p05265773/?utm_source=PRN

The report predicts the global transdermal drug delivery system market to grow with a CAGR of 4.3% over the forecast period from 2019-2025. The study on transdermal drug delivery system market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on transdermal drug delivery system market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global transdermal drug delivery system market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global transdermal drug delivery system market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

• Rise in geriatric population

• Increasing prevalence of chronic diseases such as cardiac diseases and cancer

2) Restraints

• Limited availability of transdermal drugs

3) Opportunities

• Increasing innovations in transdermal drug delivery systems

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

1. Key Opinion Leaders associated with Infinium Global Research

2. Internal and External subject matter experts

3. Professionals and participants from the industry

Our primary research respondents typically include

1. Executives working with leading companies in the market under review

2. Product/brand/marketing managers

3. CXO level executives

4. Regional/zonal/ country managers

5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications

2. Government/institutional publications

3. Trade and associations journals

4. Databases such as WTO, OECD, World Bank, and among others.

5. Websites and publications by research agencies

Segment Covered

The global transdermal drug delivery system market is segmented on the basis of product, application, and facility of use.

The Global Transdermal Drug Delivery System Market by Product

• Transdermal Patches

• Transdermal Gels

The Global Transdermal Drug Delivery System Market by Application

• Cardiovascular Disease

• Central Nervous System Disorders

• Pain Management

• Hormonal Conditions

• Other Applications

The Global Transdermal Drug Delivery System Market by Facility of Use

• Hospitals and Clinics

• Homecare Settings

• Surgical Centers

Company Profiles

• Allergan plc

• The 3M Company

• Novartis AG

• Biogel Technology, Inc.

• Echo Therapeutics Inc.

• Crescita Therapeutics Inc.

• Noven Pharmaceuticals, Inc.

• Vectura Group plc

• Pantec Biosolutions AG

• Other Companies

What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the transdermal drug delivery system market.

2. Complete coverage of all the segments in the transdermal drug delivery system market to analyze the trends, developments in the global market and forecast of market size up to 2025.

3. Comprehensive analysis of the companies operating in the global transdermal drug delivery system market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Read the full report: https://www.reportlinker.com/p05265773/?utm_source=PRN

About Reportlinker

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Contact Clare: clare@reportlinker.com

US: (339)-368-6001

Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

http://www.reportlinker.com

Categories
Uncategorized
No Comment

Leave a Reply

*

*

RELATED BY